← Eichor
Study identifier: NCT07214948 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Open, Randomized Feasibility Trial on the Safety and Performance of the INGA Catheter for Labor Induction

Condition: Induction of Birth · Cervical Ripening · Cervical Ripening and Induction of Labor  ·  Sponsor: Aalto University

PhaseNA
Planned participants40
Who can joinFemale, 18 Years to 56 Years
Healthy volunteersNo

About this study

This study investigates the safety and usability of the new INGA catheter for labor induction. Labor induction is common, with about one in three births being induced. In this study, the INGA catheter will be compared to a currently used method. The INGA catheter is a single-balloon device that works similarly to a Foley catheter but is made from different materials. Feedback will be collected from both healthcare professionals and participating women.

This description comes directly from the study's public registry record.

Talk to the study team

Kirsi Roivainen, Master of Health  ·  +358505347653  ·  kirsi.roivainen@mdsfinland.com

Heidi Kruit, MD, PhD, Associate Professor  ·  +358504284685  ·  heidi.kruit@hus.fi

Always discuss trial participation with your own doctor first.

Locations (2)

University of Minnesota Medical SchoolMinneapolis, Minnesota, United StatesRecruiting
University of Mississippi Medical CenterJackson, Mississippi, United StatesNot Yet Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07214948